The clinical and rehabilitative complexity in dementia with Lewy bodies (DLB): Experience on a random sample of elderly patients dwelling in an RSA (“Residenza Sanitaria Assistita”) of Catania

2010 ◽  
Vol 51 (1) ◽  
pp. e7-e10 ◽  
Author(s):  
Antonino Santangelo ◽  
Manuela Testai’ ◽  
Salvatore Albani ◽  
Grazia Mamazza ◽  
Salvatore Pavano ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Random Sample ◽  
Dementia With Lewy Bodies ◽  
Lewy Bodies

MEMORY IMPAIRMENT IN ELDERLY PATIENTS WITH DEMENTIA WITH LEWY BODIES: MORE THAN ONE PATTERN?

2009 ◽  
Vol 57 (5) ◽  
pp. 929-930 ◽  
Author(s):  
Caroline Marquis ◽  
Zina Barrou ◽  
Sandrine Greffard ◽  
Bénédicte Dieudonne ◽  
Jacques Boddaert ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Memory Impairment ◽  
Dementia With Lewy Bodies ◽  
Lewy Bodies

Cardiac and Blood Pressure Safety of Transdermal Rivastigmine in Elderly Patients With Dementia With Lewy Bodies

2020 ◽  
Vol 34 (4) ◽  
pp. 339-343
Author(s):  
Ahmet T. Isik ◽  
Esra Ates Bulut ◽  
Ozge Dokuzlar ◽  
Derya Kaya ◽  
Neziha Erken ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Elderly Patients ◽  
Dementia With Lewy Bodies ◽  
Lewy Bodies

Differences in glucose metabolism between dementia with Lewy bodies and dementia associated with Parkinson's disease

2005 ◽  
Vol 32 (S 4) ◽  
Author(s):  
P Häussermann ◽  
A.O Ceballos-Baumann ◽  
H Förstl ◽  
R Feurer ◽  
B Conrad ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Glucose Metabolism ◽  
Dementia With Lewy Bodies ◽  
Lewy Bodies

Dementia with Lewy bodies

2018 ◽  
pp. 11-21
Author(s):  
O. S. Levin ◽  
E. E. Vasenina ◽  
A. Sh. Chimagomedova ◽  
N. G. Dudchenko
Keyword(s):  
Parkinson’S Disease ◽  
Dementia With Lewy Bodies ◽  
Cholinesterase Inhibitors ◽  
Lewy Bodies ◽  
Diagnosis And Treatment ◽  
Modern Concept ◽  
Historical Aspect ◽  
Neurodegenerative Process ◽  
Icd 10

Te lecture presents modern concept of the symptoms, diagnosis and treatment of dementia with Lewy bodies (DLB), which accounts for about 10% of cases of dementia. Te nosological status of DLB and the problem of ratio of DLB and Parkinson’s disease which, apparently, represent two phenotypic variants of one neurodegenerative process («diseases with Lewy bodies») are considered in historical aspect. Approaches to the diagnosis and coding of DLB in accordance with ICD-10 are proposed. Te role of cholinesterase inhibitors, antipsychotics, levodopa, rasagiline and other drugs in the treatment of patients with DLB is аnalyzed.

Sign in / Sign up

Export Citation Format

Share Document